| Document and Entity Information (USD $) | 12 Months Ended | ||
| Dec. 31, 2013 | Feb. 22, 2014 | Jun. 30, 2013 | |
| Document and Entity Information | ' | ' | ' |
| Entity Registrant Name | 'LIGHTTOUCH VEIN & LASER INC | ' | ' |
| Document Type | '10-K | ' | ' |
| Document Period End Date | 31-Dec-13 | ' | ' |
| Amendment Flag | 'false | ' | ' |
| Entity Central Index Key | '0001104265 | ' | ' |
| Current Fiscal Year End Date | '--12-31 | ' | ' |
| Entity Common Stock, Shares Outstanding | ' | 418,895 | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' | ' |
| Entity Current Reporting Status | 'Yes | ' | ' |
| Entity Voluntary Filers | 'No | ' | ' |
| Entity Well-known Seasoned Issuer | 'No | ' | ' |
| Document Fiscal Year Focus | '2013 | ' | ' |
| Document Fiscal Period Focus | 'FY | ' | ' |
| Entity Public Float | ' | ' | $372,610 |
| LightTouch Vein & Laser, Inc. Balance Sheets (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
| Assets: | ' | ' |
| Current assets | $0 | $0 |
| Total Assets | 0 | 0 |
| Current liabilities: | ' | ' |
| Accounts payable | 33,195 | 32,009 |
| Payable to stockholders | 115,565 | 90,140 |
| Total Liabilities | 148,760 | 122,149 |
| Stockholders' Equity(deficit): | ' | ' |
| Preferred stock, $0.001 par value, 25,000,000 shares authorized, no shares issued and outstanding | 0 | 0 |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 418,895 shares issued and outstanding | 419 | 419 |
| Additional Paid-in capital | 7,142,744 | 7,142,744 |
| Retained deficit | -7,291,923 | -7,265,312 |
| Total Stockholders' Equity (Deficit) | -148,760 | -122,149 |
| Total Liabilities and Stockholders' Equity (Deficit) | $0 | $0 |
| LightTouch Vein Laser, Inc. Balance Sheet (Parenthetical) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
| Statement of Financial Position | ' | ' |
| Preferred stock authorized | 25,000,000 | 25,000,000 |
| Preferred stock par value | $0.00 | $0.00 |
| Preferred stock outstanding | 0 | 0 |
| Preferred stock issued | 0 | 0 |
| Common stock authorized | 100,000,000 | 100,000,000 |
| Common stock par value | $0.00 | $0.00 |
| Common stock outstanding | 418,895 | 418,895 |
| Common stock issued | 418,895 | 418,895 |
| LightTouch Vein & Laser, Inc. Statements of Operations (USD $) | 12 Months Ended | |
| Dec. 31, 2013 | Dec. 31, 2012 | |
| Income Statement | ' | ' |
| Revenue | $0 | $0 |
| Operating expenses: | ' | ' |
| General and Administrative Expenses | 16,672 | 17,809 |
| Total operating expenses | 16,672 | 17,809 |
| Loss from operations | -16,672 | -17,809 |
| Other Income (Expenses): | ' | ' |
| Interest expense - related party | -9,939 | -7,291 |
| Total Other Expense | -9,939 | -7,291 |
| Net (Loss) | ($26,611) | ($25,100) |
| Net (Loss) per share of common stock | ($0.06) | ($0.06) |
| Weighted number of common shares outstanding | 418,895 | 418,895 |
| LightTouch Vein & Laser, Inc. Statements of Changes in Stockholders' Deficit (USD $) | Common Stock | Additional Paid-In Capital | Retained Earnings (Accumulated Deficit) | Total |
| Balance common shares, beginning value at Dec. 31, 2011 | 418,895 | 0 | 0 | 418,895 |
| Net loss | $0 | $0 | ($25,100) | ($25,100) |
| Stockholders' Equity, ending balance at Dec. 31, 2012 | 419 | 7,142,744 | -7,265,312 | -122,149 |
| Balance common shares, ending value at Dec. 31, 2012 | 418,895 | 0 | 0 | 418,895 |
| Net loss | 0 | 0 | -26,611 | -26,611 |
| Stockholders' Equity, ending balance at Dec. 31, 2013 | $419 | $7,142,744 | ($7,291,923) | ($148,760) |
| Balance common shares, ending value at Dec. 31, 2013 | 418,895 | 0 | 0 | 418,895 |
| LightTouch Vein & Laser, Inc. Statements of Cash Flows (USD $) | 12 Months Ended | |
| Dec. 31, 2013 | Dec. 31, 2012 | |
| Cash flows from operating activities: | ' | ' |
| Net loss | ($26,611) | ($25,100) |
| Increase (decrease) in accounts payable | 1,186 | 4,882 |
| Increase (decrease) in payable to stockholders and related party | 25,425 | 20,218 |
| Net Cash used in operating activities | 0 | 0 |
| Net Cash Provided by Investing Activities | 0 | 0 |
| Net Cash Provided by Financing Activities | 0 | 0 |
| Net change in cash | 0 | 0 |
| Cash, beginning of period | 0 | 0 |
| Cash, end of period | 0 | 0 |
| Supplemental disclosure of cash flow information: | ' | ' |
| Income taxes | 0 | 0 |
| Interest | $0 | $0 |
| Summary of Significant Accounting Policies | 12 Months Ended |
| Dec. 31, 2013 | |
| Notes | ' |
| Summary of Significant Accounting Policies | ' |
| Note 1: Summary of Significant Accounting Policies | |
| Organization – LightTouch Vein & Laser, Inc. (the “Company”) was organized under the laws of the State of Nevada on May 1, 1981 under the name of Strachan, Inc. and during 1999, the Company changed its name to its present name. Between 1999 and 2000, the Company acquired several subsidiary corporations and conducted its business operations primarily through them. Subsequent to August 2000, financial difficulties prevented these subsidiary corporations from operating profitably and each of them ceased operations. In most cases these subsidiary corporations filed for bankruptcy in the applicable federal court, the proceedings of which lasted in some cases through 2005. At the present time the Company is seeking a business combination with an operating entity through a reverse acquisition. | |
| Going Concern – The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has not conducted any revenue producing operations during the past several years, has no assets but has incurred liabilities of $148,760 as of December 31, 2013. These factors raise substantial doubt concerning the ability of the Company to continue as a going concern. The Company’s sole officer and an affiliate have paid the Company’s expenses (See Note 3. Related Party Transactions). An amount of $115,565, which includes accrued interest, is due them as of December 31, 2013. The Company proposes to continue this method of paying for its expenses unless other capital raising means can be employed, of which there can be no assurance that such will be available. In addition, the Company is dependent on its management serving without monetary remuneration. The Company assumes that its arrangement with management will continue into the future. These financial statements do not include any adjustments that might result from a negative outcome of these uncertainties. A change in these circumstances would have a material negative effect on the Company's future. | |
| Use of Estimates – These financial statements are prepared in conformity with accounting principles generally accepted in the United States of America and require that management make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. The use of estimates and assumptions may also affect the reported amounts of revenues and expenses. Actual results could differ from those estimates or assumptions. | |
| (Loss) Per Common Share – The loss per share of common stock is computed by dividing the net loss during the period presented by the weighted average number of shares of common stock outstanding during that same period. There were no potential common shares outstanding during any period presented that would result in a dilution to the actual number of common shares outstanding. However, the Company may have a contingent obligation to issue additional shares based on acquisitions that the Company made of entities that became subsidiaries of the Company. Such contingent obligation has not been given consideration in computing the loss per common share (See Note 2: Capital Stock). | |
| Income taxes – The Company has no deferred taxes arising from temporary differences between income for financial reporting and for income tax purposes. Deferred tax assets and liabilities are measured using enacted tax rates to taxable income in the years in which those temporary differences are expected to reverse. A valuation allowance is provided for deferred tax assets if it is more likely than not that these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. | |
| At December 31, 2013, the Company has a net operating loss carry forward of approximately $169,600 that expires if unused through 2033. A deferred tax asset in the amount of $25,440 is fully offset by a valuation allowance in the same amount. The change in the valuation allowance was $3,990 and $3,750 for the years ended December 31, 2013 and 2012, respectively. The Company’s likelihood to utilize any net operating loss carry forward from years prior to 2007 is remote as a result of its intended change in business activities and other tax regulations relating to those prior years. | |
| The Company adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, on January 1, 2007. As a result of the implementation of Interpretation 48, the Company recognized approximately no increase in the liability for unrecognized tax benefits. | |
| The Company has no tax positions at December 31, 2013 and 2012 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. | |
| The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the years ended December 31, 2013 and 2012, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2013 and 2012. | |
| Recently Enacted Accounting Standards | |
| The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. | |
| Capital Stock | 12 Months Ended |
| Dec. 31, 2013 | |
| Notes | ' |
| Capital Stock | ' |
| Note 2: Capital Stock | |
| Preferred Stock – The Company is authorized to issue 25,000,000 shares of preferred stock, $.001 par value, with such rights, preferences, variations and such other designations for each class or series within a class as determined by the Board of Directors. The preferred stock is not convertible into common stock, does not contain any cumulative voting privileges, and does not have any preemptive rights. No shares of preferred stock have been issued. | |
| Common Stock – On August 15, 2000, the Company acquired Vanishing Point, Inc. (“Vanishing Point”) as a wholly-owned subsidiary through a triangular reorganization whereby an existing subsidiary of the Company acquired all of the Vanishing Point common stock, options to acquire common stock, warrants, and convertible notes (collectively the “Exchange Securities”) in exchange for 85,766 shares of the Company’s common stock. The conditions of the exchange require that the Exchange Securities be surrendered to the Company’s transfer agent and that payment, either in services or in a cash amount, be made to the Company. As a result of the demise of the business operations of the Company’s subsidiaries shortly after the Vanishing Point acquisition, both the terms and conditions of surrendering the Exchange Securities were not completed. The Company believes that all properly allowable issuances of the Company’s common stock for the Exchange Securities have occurred, but no assurance thereof can be given. (See Note 4: Contingent Liabilities) | |
| During the year ended December 31, 2010, the sole officer of the Company converted a note in the amount of $25,000 into 250,000 shares of common stock of the Company. The stock was valued at $0.10 per share which approximated market value. | |
| Pursuant to approval of the Company’s management and shareholders on June 17, 2013, effective July 16, 2013, the Company recapitalized the issued and outstanding shares of common stock which resulted in the outstanding shares of the Company being reduced from 40,969,007 to approximately 418,895 through a reverse split of the issued and outstanding common stock on a one (1) for one hundred (100) basis, after taking into account rounding of shares. The effects of the reverse stock split have been shown retroactively in these financial statements. |
| Related Party Transactions | 12 Months Ended |
| Dec. 31, 2013 | |
| Notes | ' |
| Related Party Transactions | ' |
| Note 3: Related Party Transactions | |
| Commencing in 2006, the Company’s sole officer made payment of general and administrative expenses incurred by the Company and in 2007 entered into an unsecured line of credit note. This note bears interest at a rate of 18% per annum and has been extended on several occasions. Commencing in 2008, an affiliate of the Company’s sole officer made similar payment of general and administrative expenses incurred by the Company at a rate of 18% per annum. Furthermore, certain general and administrative expenses related to the Company maintaining an office and filing its reports with the Securities and Exchange Commission have been accrued and are payable to the Company’s sole officer and affiliate. Collectively, these amounts total $115,564 and $90,140 at December 31, 2013 and 2012, respectively. Accrued interest included in these amounts is $38,779 and $28,840 at December 31, 2013 and 2012, respectively. |
| Subsequent Events | 12 Months Ended |
| Dec. 31, 2013 | |
| Notes | ' |
| Subsequent Events | ' |
| Note 4: Subsequent Events | |
| The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no events that require disclosure except as set forth herein. On March 26, 2014, the Company entered into a promissory note with an entity controlled by the Company’s sole officer and director to memorialize prior loans to the Company. Under the terms of the note, it may be converted into shares of the Company at the rate of one share of common stock for every $0.25 in principal and interest. The note may not be converted, at any one time, into more than 4.9% of the Company’s issued and outstanding shares of Common Stock unless a change of control occurs or a fundamental transaction which would include a merger, reorganization or asset sale. Under the terms of the note, the note is payable one year from its origination. The note bears interest at the rate of eighteen percent (18%) per annum. |
| Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
| Dec. 31, 2013 | |
| Policies | ' |
| Summary of Significant Accounting Policies | ' |
| Organization – LightTouch Vein & Laser, Inc. (the “Company”) was organized under the laws of the State of Nevada on May 1, 1981 under the name of Strachan, Inc. and during 1999, the Company changed its name to its present name. Between 1999 and 2000, the Company acquired several subsidiary corporations and conducted its business operations primarily through them. Subsequent to August 2000, financial difficulties prevented these subsidiary corporations from operating profitably and each of them ceased operations. In most cases these subsidiary corporations filed for bankruptcy in the applicable federal court, the proceedings of which lasted in some cases through 2005. At the present time the Company is seeking a business combination with an operating entity through a reverse acquisition. | |
| Going Concern | ' |
| Going Concern – The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has not conducted any revenue producing operations during the past several years, has no assets but has incurred liabilities of $148,760 as of December 31, 2013. These factors raise substantial doubt concerning the ability of the Company to continue as a going concern. The Company’s sole officer and an affiliate have paid the Company’s expenses (See Note 3. Related Party Transactions). An amount of $115,565, which includes accrued interest, is due them as of December 31, 2013. The Company proposes to continue this method of paying for its expenses unless other capital raising means can be employed, of which there can be no assurance that such will be available. In addition, the Company is dependent on its management serving without monetary remuneration. The Company assumes that its arrangement with management will continue into the future. These financial statements do not include any adjustments that might result from a negative outcome of these uncertainties. A change in these circumstances would have a material negative effect on the Company's future. | |
| Use of Estimates | ' |
| Use of Estimates – These financial statements are prepared in conformity with accounting principles generally accepted in the United States of America and require that management make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. The use of estimates and assumptions may also affect the reported amounts of revenues and expenses. Actual results could differ from those estimates or assumptions. | |
| Net Loss Per Share of Common Stock | ' |
| (Loss) Per Common Share – The loss per share of common stock is computed by dividing the net loss during the period presented by the weighted average number of shares of common stock outstanding during that same period. There were no potential common shares outstanding during any period presented that would result in a dilution to the actual number of common shares outstanding. However, the Company may have a contingent obligation to issue additional shares based on acquisitions that the Company made of entities that became subsidiaries of the Company. Such contingent obligation has not been given consideration in computing the loss per common share (See Note 2: Capital Stock). | |
| Income Taxes | ' |
| Income taxes – The Company has no deferred taxes arising from temporary differences between income for financial reporting and for income tax purposes. Deferred tax assets and liabilities are measured using enacted tax rates to taxable income in the years in which those temporary differences are expected to reverse. A valuation allowance is provided for deferred tax assets if it is more likely than not that these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. | |
| At December 31, 2013, the Company has a net operating loss carry forward of approximately $169,600 that expires if unused through 2033. A deferred tax asset in the amount of $25,440 is fully offset by a valuation allowance in the same amount. The change in the valuation allowance was $3,990 and $3,750 for the years ended December 31, 2013 and 2012, respectively. The Company’s likelihood to utilize any net operating loss carry forward from years prior to 2007 is remote as a result of its intended change in business activities and other tax regulations relating to those prior years. | |
| The Company adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes, on January 1, 2007. As a result of the implementation of Interpretation 48, the Company recognized approximately no increase in the liability for unrecognized tax benefits. | |
| The Company has no tax positions at December 31, 2013 and 2012 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. | |
| The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the years ended December 31, 2013 and 2012, the Company recognized no interest and penalties. The Company had no accruals for interest and penalties at December 31, 2013 and 2012. | |
| Recently Enacted Accounting Standards | ' |
| Recently Enacted Accounting Standards | |
| The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. | |
| Summary of Significant Accounting Policies (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
| Details | ' | ' |
| Total Liabilities | $148,760 | $122,149 |
| Total Amount Due Related Parties | 115,565 | ' |
| Tax Credit Carryforward, Amount | 169,600 | ' |
| Tax Credit Carryforward, Deferred Tax Asset | 25,440 | ' |
| Tax Credit Carryforward, Valuation Allowance | $3,990 | $3,750 |
| Capital Stock (Details) (USD $) | 12 Months Ended | |||
| Dec. 31, 2013 | Dec. 31, 2010 | Dec. 31, 2012 | Dec. 31, 2011 | |
| Details | ' | ' | ' | ' |
| Preferred stock authorized | 25,000,000 | ' | 25,000,000 | ' |
| Preferred stock par value | $0.00 | ' | $0.00 | ' |
| Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 85,766 | ' | ' | ' |
| Converted note into shares amount | $25,000 | ' | ' | ' |
| Converted note into shares | 250,000 | ' | ' | ' |
| Conversion of debt value per share | ' | $0.10 | ' | ' |
| Previous shares outstanding | 40,969,007 | ' | ' | ' |
| Common stock outstanding | 418,895 | ' | 418,895 | 418,895 |
| Stockholders' Equity, Reverse Stock Split | 'reverse split of the issued and outstanding common stock on a one (1) for one hundred (100) basis, after taking into account rounding of shares | ' | ' | ' |
| Related Party Transactions (Details) (USD $) | 12 Months Ended | |||
| Dec. 31, 2008 | Dec. 31, 2007 | Dec. 31, 2013 | Dec. 31, 2012 | |
| Details | ' | ' | ' | ' |
| Related party transaction rate | 18.00% | 18.00% | ' | ' |
| Related party transaction total | ' | ' | $115,564 | $90,140 |
| related party accrued interest | ' | ' | $38,779 | $28,840 |
| Subsequent Events (Details) | 12 Months Ended | ||
| Dec. 31, 2013 | Dec. 31, 2008 | Dec. 31, 2007 | |
| Details | ' | ' | ' |
| Related Party Transaction, Description of Transaction | 'Under the terms of the note, it may be converted into shares of the Company at the rate of one share of common stock for every $0.25 in principal and interest. The note may not be converted, at any one time, into more than 4.9% of the Company’s issued and outstanding shares of Common Stock unless a change of control occurs or a fundamental transaction which would include a merger, reorganization or asset sale. | ' | ' |
| Related party transaction rate | ' | 18.00% | 18.00% |
